|
|
Blood, 15 November 2006, Vol. 108, No. 10, pp. 3245-3252.
Prepublished online as a Blood First Edition Paper on July 20, 2006; DOI 10.1182/blood-2006-01-017459.
Previous Article | Next Article 
Submitted January 23, 2006
Accepted July 3, 2006
SDF-1 regulation in breast cancer cells contacting
bone marrow stroma is critical for normal hematopoiesis
Anabella Moharita, Marcelo Taborga, Kelly Corcoran, Margarette Bryan, Prem Patel, and Pranela Rameshwar*
Graduate School of Biomedical Sciences, UMDNJ
Department of Medicine-Hematology/Oncology, New Jersey Medical School, UMDNJ
Brookdale University Hospital and Medical Center, Department of Surgery, Brooklyn, NY
* Corresponding author; email: rameshwa{at}umdnj.edu.
Breast cancer (BC) cells (BCCs) show preference for the
bone marrow (BM). An animal model showed two populations
of BCCs in the BM with regards to their cycling states. An
in vitro model of early BC entry into BM showed normal
hematopoiesis. Here we show a critical role for
BCC-derived SDF-1 in hematopoietic regulation. The
studies used a co-culture of BM stroma and BCCs (cell
lines and Stage II BCCs). Northern blots and ELISA showed
gradual decreases in SDF-1 production in BCCs as
they contact BM stroma. SDF-1 knockdown BCCs, and
increased exogenous SDF-1 prevented contact
inhibition between BCCs and BM stroma. Contact inhibition
was restored with low SDF-1 levels. Long-term
culture initiating assays with
CD34+/CD38-/Lin- showed
normal hematopoiesis providing SDF-1 levels were
reduced in BCCs. Gap junctions (Cx-43) were formed between
BCCs and BM stroma with concomitant interaction between
CD34+/CD38-/Lin- and BM
stroma, but not with the neighboring BCCs. In summary,
SDF-1 levels are reduced in BCCs that contact BM
stroma. The low levels of SDF-1 in BCCs regulate
interactions between BM stroma and hematopoietic
progenitors, consequently facilitating normal
hematopoiesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. E Corcoran, A. Malhotra, C. A Molina, and P. Rameshwar
Stromal-derived factor-1{alpha} induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells
J. Mol. Endocrinol.,
March 1, 2008;
40(3):
113 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Corcoran and P. Rameshwar
Nuclear Factor-{kappa}B Accounts for the Repressor Effects of High Stromal Cell-Derived Factor-1{alpha} Levels on Tac1 Expression in Nontumorigenic Breast Cells
Mol. Cancer Res.,
April 1, 2007;
5(4):
373 - 381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Ramkissoon, P. S. Patel, M. Taborga, and P. Rameshwar
Nuclear Factor-{kappa}B Is Central to the Expression of Truncated Neurokinin-1 Receptor in Breast Cancer: Implication for Breast Cancer Cell Quiescence within Bone Marrow Stroma
Cancer Res.,
February 15, 2007;
67(4):
1653 - 1659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Corcoran, N. Patel, and P. Rameshwar
Stromal Derived Growth Factor-1{alpha}: Another Mediator in Neural-Emerging Immune System through Tac1 Expression in Bone Marrow Stromal Cells
J. Immunol.,
February 15, 2007;
178(4):
2075 - 2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|